| Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
---|
Profit (loss) before tax | 40,578 | 46,557 | 48,315 | 53,336 | 57,459 |
---|
Depreciation and amortization | 16,782 | 18,433 | 19,881 | 20,629 | 21,433 |
---|
Impairment losses (reversal of impairment losses) | 508 | - | 147 | 44 | 213 |
---|
Finance income | -212 | -160 | -94 | -1,651 | -615 |
---|
Finance costs | 658 | 478 | 587 | 589 | 1,554 |
---|
Share of loss (profit) of investments accounted for using equity method | -976 | -997 | -1,252 | -913 | -1,394 |
---|
Decrease (increase) in trade and other receivables | 240 | -3,211 | -4,220 | -8,477 | -1,622 |
---|
Decrease (increase) in contract assets | -1,905 | 539 | 3,136 | -4,286 | -542 |
---|
Decrease (increase) in inventories | -1,509 | 2,348 | -1,414 | -622 | 1,809 |
---|
Increase (decrease) in trade and other payables | 2,222 | -3,049 | 2,832 | 3,010 | 478 |
---|
Increase (decrease) in contract liabilities | 2,113 | 1,974 | -554 | 1,136 | 1,769 |
---|
Increase (decrease) in employee benefits - OpeCF (IFRS) | 1,734 | -1,132 | -996 | -8 | 1,292 |
---|
Increase (decrease) in provisions | 252 | -452 | 202 | 145 | 221 |
---|
Other | 2,703 | -3,389 | -691 | -889 | 1,922 |
---|
Subtotal | 63,189 | 57,939 | 65,877 | 62,042 | 83,979 |
---|
Interest and dividends received | 381 | 395 | 384 | 559 | 744 |
---|
Interest paid | -375 | -431 | -506 | -558 | -667 |
---|
Income taxes refund (paid) | -7,485 | -7,684 | -6,674 | -18,450 | -16,155 |
---|
Net cash provided by (used in) operating activities | 55,710 | 50,219 | 59,081 | 43,592 | 67,900 |
---|
Purchase of property, plant and equipment | -9,861 | -12,710 | -10,157 | -9,681 | -4,602 |
---|
Proceeds from sale of property, plant and equipment | 1 | 68 | 8 | - | 98 |
---|
Purchase of intangible assets | -3,183 | -4,554 | -3,927 | -4,630 | -4,991 |
---|
Proceeds from sale of intangible assets | - | 9 | 73 | 44 | - |
---|
Investments in equity accounted investees | - | -553 | -296 | -203 | -361 |
---|
Purchase of other financial assets | -2,102 | -2,350 | -683 | -1,264 | -36,273 |
---|
Proceeds from sale and redemption of other financial assets | 49 | 313 | 268 | 1,352 | 32,177 |
---|
Payments for acquisition in subsidiaries resulting in change in scope of consolidation | -12,590 | - | - | - | -5,042 |
---|
Other | 202 | -808 | -213 | -568 | -903 |
---|
Net cash provided by (used in) investing activities | -27,484 | -20,586 | -14,927 | -14,950 | -19,898 |
---|
Payments for repayments of loans and redemption of bonds | -15,414 | -25,900 | -25,100 | -17,000 | -21,950 |
---|
Proceeds from long-term debt-FinCF (IFRS) | 15,300 | 15,600 | 11,500 | 12,250 | 11,500 |
---|
Proceeds from issuance of bonds | - | - | 4,972 | - | 9,950 |
---|
Repayments of lease liabilities | -7,204 | -8,590 | -9,086 | -8,998 | -8,453 |
---|
Capital contribution from non-controlling interests | - | - | - | 75 | - |
---|
Dividends paid | -11,967 | -13,526 | -14,567 | -15,406 | -16,867 |
---|
Dividends paid to non-controlling interests | -55 | -54 | -50 | -59 | -51 |
---|
Other | -13 | -16 | -9 | 65 | -9 |
---|
Net cash provided by (used in) financing activities | -22,923 | -32,488 | -32,342 | -29,074 | -25,881 |
---|
Effect of exchange rate changes on cash and cash equivalents | -19 | -71 | 672 | 605 | 814 |
---|
Net increase (decrease) in cash and cash equivalents | 5,281 | -2,927 | 12,483 | 173 | 22,934 |
---|